vs

Side-by-side financial comparison of INVO Fertility, Inc. (IVF) and AIRWA INC. (YYAI). Click either name above to swap in a different company.

AIRWA INC. is the larger business by last-quarter revenue ($3.0M vs $1.8M, roughly 1.7× INVO Fertility, Inc.). AIRWA INC. runs the higher net margin — -7.4% vs -150.5%, a 143.1% gap on every dollar of revenue. On growth, AIRWA INC. posted the faster year-over-year revenue change (729.8% vs 22.6%). Over the past eight quarters, AIRWA INC.'s revenue compounded faster (14.3% CAGR vs 12.8%).

INVO Fertility, Inc. is a specialized healthcare company focused on delivering accessible assisted reproductive technology solutions. It develops, manufactures and markets the patented INVOcell intravaginal culture system for in vitro fertilization procedures, serving fertility clinics and patients across North America, Europe and other global regions, with a mission to reduce barriers to high-quality fertility care.

Flying W Airways (FWA) was a briefly high-profile publicly-traded company of the late 1960s/early 1970s, which originated in 1961 when its founders opened Flying W Airport in New Jersey as a fly-in resort. FWA became a bet on Alaskan oil and at its peak in 1969 attracted investment by the Matlack family, had two Hollywood actors on its board and bought Red Dodge Aviation (RDA) of Alaska, for which it acquired Lockheed L-100 Hercules aircraft, to take advantage of forthcoming Alaska pipeline c...

IVF vs YYAI — Head-to-Head

Bigger by revenue
YYAI
YYAI
1.7× larger
YYAI
$3.0M
$1.8M
IVF
Growing faster (revenue YoY)
YYAI
YYAI
+707.2% gap
YYAI
729.8%
22.6%
IVF
Higher net margin
YYAI
YYAI
143.1% more per $
YYAI
-7.4%
-150.5%
IVF
Faster 2-yr revenue CAGR
YYAI
YYAI
Annualised
YYAI
14.3%
12.8%
IVF

Income Statement — Q3 FY2025 vs Q2 FY2026

Metric
IVF
IVF
YYAI
YYAI
Revenue
$1.8M
$3.0M
Net Profit
$-2.6M
$-221.8K
Gross Margin
75.2%
Operating Margin
-93.1%
1.8%
Net Margin
-150.5%
-7.4%
Revenue YoY
22.6%
729.8%
Net Profit YoY
-62.2%
83.8%
EPS (diluted)
$-0.77
$-0.05

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
IVF
IVF
YYAI
YYAI
Q4 25
$3.0M
Q3 25
$1.8M
$3.0M
Q2 25
$1.9M
$3.0M
Q1 25
$1.6M
$3.3M
Q4 24
$1.7M
$3.3M
Q3 24
$1.4M
$3.3M
Q2 24
$1.8M
$-701.1K
Q1 24
$1.6M
Net Profit
IVF
IVF
YYAI
YYAI
Q4 25
$-221.8K
Q3 25
$-2.6M
$1.3M
Q2 25
$-5.3M
$552.2K
Q1 25
$-17.4M
$-411.2K
Q4 24
$-3.6M
$-1.4M
Q3 24
$-1.6M
$-4.2M
Q2 24
$-2.2M
Q1 24
$-1.6M
Gross Margin
IVF
IVF
YYAI
YYAI
Q4 25
75.2%
Q3 25
75.2%
Q2 25
75.2%
Q1 25
35.2%
77.3%
Q4 24
41.4%
77.3%
Q3 24
31.0%
77.3%
Q2 24
53.1%
Q1 24
45.3%
Operating Margin
IVF
IVF
YYAI
YYAI
Q4 25
1.8%
Q3 25
-93.1%
49.7%
Q2 25
-160.4%
42.7%
Q1 25
-1042.1%
16.2%
Q4 24
-202.0%
71.2%
Q3 24
-90.7%
74.6%
Q2 24
-100.9%
Q1 24
-95.7%
Net Margin
IVF
IVF
YYAI
YYAI
Q4 25
-7.4%
Q3 25
-150.5%
42.0%
Q2 25
-283.6%
18.4%
Q1 25
-1060.1%
-12.6%
Q4 24
-211.3%
-41.7%
Q3 24
-113.8%
-129.0%
Q2 24
-122.2%
Q1 24
-101.3%
EPS (diluted)
IVF
IVF
YYAI
YYAI
Q4 25
$-0.05
Q3 25
$-0.77
Q2 25
$-13.30
Q1 25
$-12.53
$-1.41
Q4 24
$14.86
$6.43
Q3 24
$-15.11
$-1.91
Q2 24
$-22.39
$-30.98
Q1 24
$-7.55

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
IVF
IVF
YYAI
YYAI
Cash + ST InvestmentsLiquidity on hand
$107.0M
Total DebtLower is stronger
$2.0M
Stockholders' EquityBook value
$5.8M
$165.4M
Total Assets
$18.8M
$172.1M
Debt / EquityLower = less leverage
0.34×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
IVF
IVF
YYAI
YYAI
Q4 25
$107.0M
Q3 25
$2.5M
Q2 25
$1.4M
Q1 25
$4.3M
Q4 24
$18.1M
Q3 24
$18.2M
Q2 24
$1.8M
Q1 24
Total Debt
IVF
IVF
YYAI
YYAI
Q4 25
Q3 25
$2.0M
Q2 25
$4.8M
Q1 25
Q4 24
$7.5M
Q3 24
Q2 24
Q1 24
Stockholders' Equity
IVF
IVF
YYAI
YYAI
Q4 25
$165.4M
Q3 25
$5.8M
$26.2M
Q2 25
$2.6M
$25.3M
Q1 25
$3.3M
$26.1M
Q4 24
$12.7M
$8.0M
Q3 24
$-23.3K
$9.4M
Q2 24
$1.4M
$9.6M
Q1 24
$10.2K
Total Assets
IVF
IVF
YYAI
YYAI
Q4 25
$172.1M
Q3 25
$18.8M
$34.7M
Q2 25
$19.3M
$32.9M
Q1 25
$31.7M
$30.7M
Q4 24
$46.4M
$21.6M
Q3 24
$17.0M
$23.2M
Q2 24
$17.8M
$23.2M
Q1 24
$17.3M
Debt / Equity
IVF
IVF
YYAI
YYAI
Q4 25
Q3 25
0.34×
Q2 25
1.83×
Q1 25
Q4 24
0.59×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
IVF
IVF
YYAI
YYAI
Operating Cash FlowLast quarter
$-1.8M
$-30.8M
Free Cash FlowOCF − Capex
$-1.8M
FCF MarginFCF / Revenue
-101.6%
Capex IntensityCapex / Revenue
0.5%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-7.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
IVF
IVF
YYAI
YYAI
Q4 25
$-30.8M
Q3 25
$-1.8M
$-1.1M
Q2 25
$-1.7M
$-423.7K
Q1 25
$-3.5M
$-133.8K
Q4 24
$-617.4K
$779.4K
Q3 24
$-640.8K
$-601.3K
Q2 24
$-1.5M
$-460.3K
Q1 24
$-260.6K
Free Cash Flow
IVF
IVF
YYAI
YYAI
Q4 25
Q3 25
$-1.8M
Q2 25
$-1.7M
Q1 25
$-3.6M
Q4 24
$-696.3K
Q3 24
Q2 24
$-1.5M
Q1 24
$-310.3K
FCF Margin
IVF
IVF
YYAI
YYAI
Q4 25
Q3 25
-101.6%
Q2 25
-92.6%
Q1 25
-216.9%
Q4 24
-40.6%
Q3 24
Q2 24
-82.3%
Q1 24
-19.7%
Capex Intensity
IVF
IVF
YYAI
YYAI
Q4 25
Q3 25
0.5%
Q2 25
0.5%
Q1 25
0.9%
Q4 24
4.6%
Q3 24
0.0%
Q2 24
3.0%
Q1 24
3.2%
Cash Conversion
IVF
IVF
YYAI
YYAI
Q4 25
Q3 25
-0.86×
Q2 25
-0.77×
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons